Evidence map›Paper›PMID 31046767›Full record

ArticleBMC medical genomics2019

Structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous T-cell lymphoma, Sézary syndrome, and HIV infection.

Mark H Kaplan, Mark Kaminski, Judith M Estes, Scott D Gitlin, Joseph Zahn, James T Elder, Trilokraj Tejasvi, Elizabeth Gensterblum, Amr H Sawalha, Joseph Patrick McGowan and 7 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Mark H KaplanDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Mark KaminskiDivision of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Judith M EstesDivision of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Scott D GitlinDivision of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Joseph ZahnDivision of Dermatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
James T ElderDivision of Dermatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Trilokraj TejasviDivision of Dermatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Elizabeth GensterblumDivision of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Amr H SawalhaDivision of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.
Joseph Patrick McGowanDivision of Infectious Diseases, The Feinstein Institute for Medical research, Manhasset, NY, 11030, USA.
Michael H DosikHematology Oncology Associates, Setauket, NY, 11776, USA.
Haner DireskeneliDivision of Rheumatology, School of Medicine, Marmara University, Istanbul, Turkey.
Guher Saruhan DireskeneliDepartment of Physiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Sally N AdebamowoDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Clement A AdebamowoDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Mohammad SajadiInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Rafael Contreras-GalindoDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA. rafaelc@med.umich.edu.
University of Michigan–Ann Arbor · USUniversity of Maryland, Baltimore · USFeinstein Institute for Medical Research · USHematology Oncology Associates · USHormel (United States) · USIstanbul University · TRMarmara University · TR

Funding

NATURAL HISTORY OF AIDS IN HOMOSEXUAL MENU01AI035040 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DETELS, ROGER, MARTINEZ-MAZA, OTONIEL · 1993 to 2018
$75.2M
University of Pittsburgh Multicenter AIDS Cohort Study (MACS)U01AI035041 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MARTINSON, JEREMY JAMES, RINALDO, CHARLES R · 1993 to 2018
$71.4M
MULTICENTER AIDS COHORT STUDYU01AI035039 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLINSKY, STEVEN M · 1993 to 2018
$66.4M
Multicenter Aids Cohort Study- Part B (Baltimore Site)U01AI035042 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BROWN, TODD T, MARGOLICK, JOSEPH B. · 1993 to 2018
$61.5M
Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center - Admin Supplement: Vision and dual sensory loss in HIV-infected older adultsU01HL146201 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI TODD T BROWN, Joseph B. Margolick · 2019 to 2026
$33.7M
Center for the Analysis & Management of the Multicenter AIDS Cohort StudyUM1AI035043 · NIAID · JOHNS HOPKINS UNIVERSITY · PI D'SOUZA, GYPSYAMBER, JACOBSON, LISA P · 2012 to 2018
$20.7M
HIV-1 acidic epitope discovery from broadly neutralizing seroantibodiesR01AI110259 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SAJADI, MOHAMMAD MOHSENI · 2015 to 2019
$1.9M
AFRICAN FEMALE BREAST CANCER EPIDERMIOLOGY (AFBRECANE) STUDYU01HG009784 · NHGRI · INSTITUTE OF HUMAN VIROLOGY · PI ADEBAMOWO, CLEMENT ADEBAYO · 2017 to 2021
$1.5M
Training Program in Nigeria for NCD Research (TRAPING - NCD)D43TW009106 · FIC · UNIVERSITY OF MARYLAND BALTIMORE · PI ADEBAMOWO, CLEMENT ADEBAYO · 2011 to 2015
$1.1M
Human Endogenous Retroviral Sequences, a Tool to Study the Role of Centromeres inK22CA177824 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CONTRERAS, RAFAEL ALEJANDRO · 2013 to 2015
$346k
BLRD VA I01 BX002358FIC NIH HHS D43 TW009106NCATS NIH HHS UL1 TR001079NCI NIH HHS K22 CA177824NCI NIH HHS P30 CA134274NHGRI NIH HHS U01 HG009784NHLBI NIH HHS U01 HL146201NIAID NIH HHS R01 AI110259NIAID NIH HHS U01 AI035039NIAID NIH HHS U01 AI035040NIAID NIH HHS U01 AI035041NIAID NIH HHS U01 AI035042NIAID NIH HHS UM1 AI035043
6 · The paper itself

Abstract

backgroundHuman Endogenous Retroviruses type K HML-2 (HK2) are integrated into 117 or more areas of human chromosomal arms while two newly discovered HK2 proviruses, K111 and K222, spread extensively in pericentromeric regions, are the first retroviruses discovered in these areas of our genome.

methodsWe use PCR and sequencing analysis to characterize pericentromeric K111 proviruses in DNA from individuals of diverse ethnicities and patients with different diseases.

resultsWe found that the 5' LTR-gag region of K111 proviruses is missing in certain individuals, creating pericentromeric instability. K111 deletion (-/- K111) is seen in about 15% of Caucasian, Asian, and Middle Eastern populations; it is missing in 2.36% of African individuals, suggesting that the -/- K111 genotype originated out of Africa. As we identified the -/-K111 genotype in Cutaneous T-cell lymphoma (CTCL) cell lines, we studied whether the -/-K111 genotype is associated with CTCL. We found a significant increase in the frequency of detection of the -/-K111 genotype in Caucasian patients with severe CTCL and/or Sézary syndrome (n = 35, 37.14%), compared to healthy controls (n = 160, 15.6%) [p = 0.011]. The -/-K111 genotype was also found to vary in HIV-1 infection. Although Caucasian healthy individuals have a similar frequency of detection of the -/- K111 genotype, Caucasian HIV Long-Term Non-Progressors (LTNPs) and/or elite controllers, have significantly higher detection of the -/-K111 genotype (30.55%; n = 36) than patients who rapidly progress to AIDS (8.5%; n = 47) [p = 0.0097].

conclusionOur data indicate that pericentromeric instability is associated with more severe CTCL and/or Sézary syndrome in Caucasians, and appears to allow T-cells to survive lysis by HIV infection. These findings also provide new understanding of human evolution, as the -/-K111 genotype appears to have arisen out of Africa and is distributed unevenly throughout the world, possibly affecting the severity of HIV in different geographic areas.

Indexed as

Genetic VariationAnimalsCell LineCentromereEndogenous RetrovirusesGenotypeHIV InfectionsHumansLymphoma, T-Cell, CutaneousSezary SyndromeAIDSCentromeresCTCLHERV-KHIVK111Pericentromeric instability

Identifiers

PMID31046767
PMCPMC6498702
OpenAlexW2947164118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.